Healthy Skepticism Library
Items published during the years 1990 to 1999
There are 2362 items in the Healthy Skepticism Library that were published during the years 1990 to 1999.
Page 15 of 24 pages ‹ First < 13 14 15 16 17 > Last ›
HSL4697
Fletcher AP.
Prescriber profile and postmarketing surveillance.
Lancet 1993 Nov 6; 342:(8880):1179
HSL5020
Kimbel KH.
Prescriber profile and postmarketing surveillance.
Lancet 1993 Nov 6; 342:(8880):1178-9
HSL5028
Leufkens HG, Urquhart J.
Prescriber profile and postmarketing surveillance.
Lancet 1993 Nov 6; 342:(8880):1178
HSL5525
Wells F.
Prescriber profile and postmarketing surveillance.
Lancet 1993 Nov 6; 342:(8880):1178
HSL5708
WHO ethical criteria for medicinal drug promotion
1993 Nov 5
HSL5705
Information overload—presentation materials
1993 Nov
HSL5706
MacDonald G.
Aurorix® 1994 marketing plan
1993 Nov
HSL9240
Grove D.
Major opportunity in major medical
ComputerTalk Pharm 1993 Nov-Dec; 13:6-7
HSL9305
Epstein LG.
Communicating with pharmacy management companies
Med Interface 1993 Nov; 6:52-54, 57
HSL9314
Gibaldi M.
Prescription drugs and health care reform.
Pharmacotherapy 1993 Nov-Dec; 13:(6):583-9
HSL9334
Goyan JE.
Withdrawal of a drug from the market. What should the prescriber do?
JAMA. 1993 Oct 27; 270:(16):1976-7
http://www.ncbi.nlm.nih.gov/pubmed/8411557
HSL4695
Finley R.
Deceptive X-ray films in an advertisement.
N Engl J Med 1993 Oct 14; 329:(16):1207
HSL5701
Borow W.
Medical television. Prescription for progress
JAMA. 1993 Oct 6; 270:(13):1601-2
HSL1869
Forrest DM, Ruedy J.
Proposed guidelines for housestaff interaction with pharmaceutical companies.
Ann R Coll Physicians Surg Can 1993 Oct; 26:(5):291-3
HSL5019
Keim SM, Sanders AB, Witzke DB, Dyne P, Fulginiti JW.
Beliefs and practices of emergency medicine faculty and residents regarding professional interactions with the biomedical industry.
Ann Emerg Med 1993 Oct; 22:(10):1576-81
http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6WB0-4G82KSP-G&_coverDate=10%2F31%2F1993&_alid=409874800&_rdoc=1&_fmt=&_orig=search&_qd=1&_cdi=6696&_sort=d&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=c9e69f46e454e334bb60e2c0aeaf1787
HSL5250
Reeder M, Dougherty J, White LJ.
Pharmaceutical representatives and emergency medicine residents: a national survey.
Ann Emerg Med 1993 Oct; 22:(10):1593-6
http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6WB0-4G82KSP-M&_coverDate=10%2F31%2F1993&_alid=417430899&_rdoc=1&_fmt=&_orig=search&_qd=1&_cdi=6696&_sort=d&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=01124d5f2a89fef2b4262231c96031b6
HSL5699
Re: the promotion of Septrin (co-trimoxazole)
1993 Oct;
HSL5700
Summary of outcomes for topics commenced February 1991 to May 1992
MaLAM International News 1993 Oct
HSL5702
Ingram R.
Speaking out: Get ready for changes in advertising and promotion
Medical Marketing & Media 1993 Oct
HSL5703
Leisten V, Schmieder W, Wenzel J.
Proof of effectiveness: “pharma-ads”
1993 Oct
HSL5704
Van STAA.
Myth and metronidazole in Manila: the popularity of drugs among prescribers and dispensers in the treatment of diarrhoea
INRUD News 1993 Oct
HSL9302
Baichwal RS.
New dimensions in drug discovery
Pharma Times 1993 Oct; 25:15, 17, 19, 21
HSL9306
How you subsidize the drug industry
Consum Rep 1993 Oct; 670-674
HSL9307
How to buy drugs for less
Consum Rep 1993 Oct; 675-676
HSL9308
Do we pay too much for prescriptions?
Consum Rep 1993 Oct; 668-669
HSL9309
Henkel J.
User fees to fund faster reviews.
FDA Consum 1993 Oct; 27:(8):19-21
HSL9330
Turowski RC, Raskay-Bianco MM, Visconti JA.
Prescription assistance programs: options for assisting the uninsured and underinsured.
Hosp Pharm 1993 Oct; 28:(10):948,
HSL5246
Paulshock BZ.
Single-drug therapy for hypertension in men.
N Engl J Med 1993 Sep 30; 329:(14):1044-5
HSL4686
Dean M.
Conflicts of interest in drug regulation.
Lancet 1993 Sep 18; 342:(8873):732
HSL9310
Faivelson S.
Merck Medco merger
Med World News 1993 Sep 15; 34:30-31
HSL20518
Follea L
Drug companies under fire for their Third World advertising practices
Le Monde 1993 Sep 1513
HSL5164
Lexchin J.
Physicians and drug companies interact.
Can Fam Physician 1993 Sep 01; 39:1881-2
HSL5698
Borow W.
The AMA explains its about-face on direct-to-consumer advertising
Medical Marketing & Media 1993 Sep 01; 28:(9):68-69, 72, 74
HSL5695
Organon claims Tolvon has “similar levels of efficacy as amitripyline, imipramine and clomipramine, but is associated with significantly less side-effects” and is “similar in efficacy and side-effects to the newer anti-depressants with which it has been compared”
MaLAM Australian News 1993 Sep
HSL5696
Re: the promotion of Kaopectato/Kaopectate (kaolin with pectin)
1993 Sep
HSL5697
Re: the promotion of Tolvon (mianserin)
1993 Sep
HSL9311
Laskoski G.
Generics: too good for their own good
Am Drug 1993 Sep; 208:30-32, 34-35
HSL5242
Mossinghoff GJ.
Drug labelling in developing countries.
Lancet 1993 Aug 28; 342:(8870):556-7
HSL5018
Kassirer JP, Angell M.
Financial conflicts of interest in biomedical research.
N Engl J Med 1993 Aug 19; 329:(8):570-1
HSL5517
Thompson DF.
Understanding financial conflicts of interest.
N Engl J Med 1993 Aug 19; 329:(8):573-6
http://content.nejm.org/cgi/content/extract/329/8/573
HSL4694
Education Council, Residency Training Programme in Internal Medicine, Department of Medicine, McMaster University, Hamilton, Ont
Development of residency program guidelines for interaction with the pharmaceutical industry.
CMAJ 1993 Aug 15; 149:(4):405-08
HSL5529
Woollard RF.
Addressing the pharmaceutical industry's influence on professional behaviour.
CMAJ 1993 Aug 15; 149:(4):403-4
http://www.pubmedcentral.gov/articlerender.fcgi?tool=pubmed&pubmedid=8348421
HSL5527
Williams JR.
General Council to consider amendments to CMA policy on MDs' relationships with drug industry.
CMAJ 1993 Aug 1; 149:(3):335-7
http://www.pubmedcentral.gov/articlerender.fcgi?tool=pubmed&pubmedid=11659649
HSL5691
Re: the promotion of Augmentin (amoxycillin/clavulinic acid)
1993 Aug
HSL5692
SmithKline Beecham claims “when you need to be sure in otitis media and sinusitis, you need Augmentin”
MaLAM Australian News 1993 Aug
http://jcp.sagepub.com/cgi/reprint/40/10/1102
HSL5693
Bala K.
Towards ethical prescribing information
HAI News 1993 Aug
HSL9333
Vosper HJ, Frewen TC.
Physician education and prescribing costs.
Pharmacoeconomics 1993 Aug; 4:(2):77-84
HSL5167
Mann J, Crooke M, Fear H, Hay D, Jackson R, Neutze J, White H.
Pharmaceutical company sponsorship.
N Z Med J 1993 Jul 28; 106:(960):318
HSL9329
Rankin K.
New Medicare catastrophic Rx plan . . . but can pharmacy live with it?
Drug Store News for Pharm 1993 Jul 26; 3:23
HSL4681
Levine SJ, Barton TL.
Labels for nonprescription medications.
N Engl J Med 1993 Jul 22; 329:(4):280-1
HSL9321
Conlan MF.
Rx outpatient benefit for Medicare under review again
Drug Top 1993 Jul 19; 137:39
HSL20163
Liebman H
Consumer, heal thyself; ads for prescription drugs are popping up more frequently in consumer media.
Mediaweek 1993 July 5
http://business.highbeam.com/137332/article-1G1-14018400/consumer-heal-thyself-ads-prescription-drugs-popping
HSL5689
Physicians say direct-to-consumer advertising affects patient behavior.
Am J Hosp Pharm 1993 Jul 01; 50:(7):1329
HSL4659
Physicians say direct-to-consumer advertising affects patient behavior.
Am J Hosp Pharm 1993 Jul; 50:(7):1329
HSL5240
Mitchell AB.
Doctors, drug companies and free lunches: a clinical tutor's view.
J R Coll Physicians Lond 1993 Jul; 27:(3):313-4
HSL5518
Uzych L.
Direct-to-the-consumer advertising of drug products.
Pa Med 1993 Jul; 96:(7):16-7
HSL5688
Rhone-Poulenc Rorer claims Denoral is “new” and “unique”, “protects nasal mucosa” and “overcomes cough”
MaLAM International News 1993 Jul
HSL9313
Arnold RB.
Self-regulation of the promotion and marketing of prescription medicines
Drugs Made Ger 1993 Jul-Sep; 36:75-78
HSL9315
Just a spoonful of sugar...
NARD J 1993 Jul; 115:86
HSL9331
Report of pre-approval inspection program for drugs-FDA answers your questions
Pharm Eng 1993 Jul-Aug; 13:48-54
HSL9370
Physicians say direct-to-consumer advertising affects patient behavior.
Am J Hosp Pharm. 1993 Jul; 50:(7):1329
HSL5244
O'Mahony B.
Interactions between a general practitioner and representatives of drug companies.
BMJ 1993 Jun 19; 306:(6893):1649
HSL5172
Merikangas JR.
Changing over-the-counter drugs while retaining the brand name.
Ann Intern Med 1993 Jun 15; 118:(12):988
http://www.annals.org/cgi/content/full/118/12/988
HSL5516
Suresh CG, Greene D, Coupe MO.
Use of adenosine and effectiveness of pharmaceutical marketing.
Lancet 1993 Jun 12; 341:(8859):1539-40
HSL5253
Rothman KJ.
Conflict of interest. The new McCarthyism in science
JAMA 1993 Jun 02; 269:2782-2784
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8192721&dopt=Abstract
HSL4666
Andrews G.
Promoting non-drug therapies.
Aust N Z J Psychiatry 1993 Jun 01; 27:(2):341-2
HSL5168
Marley J, Mant A.
Post marketing surveillance. Traps for the unwary.
Aust Fam Physician 1993 Jun 01; 22:(6):1009-11,
HSL5515
Sullivan P.
CMA launches major campaign to support new MDs' right to practise.
CMAJ 1993 Jun 1; 148:(11):1998-2000
http://www.pubmedcentral.gov/articlerender.fcgi?tool=pubmed&pubmedid=8500037
HSL4682
Chirac P, Pikon A, Poinsignon Y, Vitry A.
Drug marketing in French-speaking African countries.
Soc Sci Med 1993 Jun; 36:(12):1541-3
HSL4690
Dixon T.
Pharmaceutical advertising Information or influence?
Can Fam Physician 1993 Jun; 39:1298-300,
HSL4704
Hogan DJ, Sarel D, Canas A, Bellman B, Eaglstein W, Hogan LA, Kramer J.
An analysis of advertisements in the Journal of the American Academy of Dermatology, 1980 and 1990.
J Am Acad Dermatol 1993 Jun; 28:(6):993-7
HSL5680
MaLAM: the industry watchdog
HAI News 1993 Jun
HSL5681
Re: the promotion of Polymagma and Entox-P (attapulgite)
1993 Jun
HSL5682
Re: the promotion of Toradol (ketorolac)
1993 Jun
HSL5683
Syntex claims Toradol has “narcotic efficacy without narcotic drawbacks”
MaLAM Australian News 1993 Jun
HSL5684
Frankel J.
Selling to doctors in Europe
Scrip Magazine 1993 Jun26-29
HSL5685
Janssen claims “adverse reactions are unlikely”
MaLAM Australian News 1993 Jun
HSL5686
Re: the promotion of Denoral (buzepide/clocinizine/pholcodine)
1993 Jun
HSL5687
Re: the promotion of Nizoral (oral ketoconazole)
1993 Jun
HSL9324
Bashe G, Murray L.
Mail order pharmacy puts Rx companies in the middle
Med Mark Media 1993 Jun; 28:20-22, 24, 26
HSL5523
Weaving PG.
Drug company representatives and sales priorities.
Lancet 1993 May 29; 341:(8857):1416
HSL4668
Ariano RE, Zelenitsky SA.
Ketorolac (Toradol): a marketing phenomenon.
CMAJ 1993 May 15; 148:(10):1686-8
HSL5257
Spickler W.
Ketorolac (Toradol): a new analgesic or an old NSAID?
CMAJ 1993 May 15; 148:(10):1693-5
HSL5022
Klein M.
Novel gifts from pharmaceutical companies.
N Engl J Med 1993 May 13; 328:(19):1426
HSL5549
Editorial
Health Horizons 1993 May
HSL5677
Re: the promotion of Periactin (cyproheptadine)
1993 May
HSL5678
Summary of outcomes for topics commenced November 1991 to January 1992
MaLAM International Newsletter 1993 May
HSL5679
Critser G.
Dealing a new antidepressant: little pills get a big push onto the market
Harper’s 1993 May54-55
HSL9317
Clark G.
Ethical rule changed again
S Afr Pharm J 1993 May; 60:146
HSL9328
Ostrowidzki V.
Drugmakers fire back
Am Drug 1993 May; 207:7-8, 9
HSL5012
Humphreys DM.
Unpublished data in drug advertisements.
BMJ 1993 Apr 24; 306:(6885):1127
HSL5169
Massam D.
Unpublished data in drug advertisements.
BMJ 1993 Apr 24; 306:(6885):1127
HSL4667
Angel JE.
Publication of sponsored symposiums in medical journals.
N Engl J Med 1993 Apr 22; 328:(16):1196
HSL4696
Finucane TE.
Publication of sponsored symposiums in medical journals.
N Engl J Med 1993 Apr 22; 328:(16):1197
HSL5017
Kasper CK.
Publication of sponsored symposiums in medical journals.
N Engl J Med 1993 Apr 22; 328:(16):1197
HSL5170
Massie BM, Rothenberg D.
Publication of sponsored symposiums in medical journals.
N Engl J Med 1993 Apr 22; 328:(16):1196-7
HSL5252
Roberts MS.
Publication of sponsored symposiums in medical journals.
N Engl J Med 1993 Apr 22; 328:(16):1197
HSL9326
Ukens C.
Multitier prices will be dead issue, pharmacists told
Drug Top 1993 Apr 19; 137:88
HSL4683
Collier J.
Drug company representatives and sales priorities.
Lancet 1993 Apr 17; 341:(8851):1031-2
HSL20005
Weaving PG
Drug company representatives and sales prioprities
The Lancet 1993 Apr 17; 341:(8851):1031-1032
http://www.mendeley.com/research/drug-company-representatives-sales-priorities/
Page 15 of 24 pages ‹ First < 13 14 15 16 17 > Last ›
